Overview Folate and Protection Against Cervical Cancer Status: Terminated Trial end date: 2007-05-01 Target enrollment: Participant gender: Summary This is a randomised double-blind placebo-controlled trial to see whether giving a low dose of the vitamins folic acid and riboflavin is beneficial to women who have very low grade abnormalities of the cervical cells. Phase: Phase 1/Phase 2 Details Lead Sponsor: Sheffield Teaching Hospitals NHS Foundation TrustCollaborator: World Cancer Research Fund InternationalTreatments: Folic AcidRiboflavinVitamin B Complex